People with "young" brains -- brains aging more slowly than their actual age -- are much less likely to die or develop ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a ...

In the latest close session, Novo Nordisk (NVO) was up +1.89% at $71.01. The stock exceeded the S&P 500, which registered a gain of 0.28% for the day. Meanwhile, the Dow gained 0.43%, and the Nasdaq, ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Mattel collaborates with a global organization specifically for type 1 diabetes to launch a Barbie doll with type 1 diabetes.

TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...

Ozempic in particular led Jeremy Clarkson to have some pretty horrible sickness, while others have noticed changes in their muscle strength, face structure and even in their downstairs area after ...

True transformation comes from embedding diversity in leadership values, not compliance. Leaders must foster safe spaces and model vulnerability.